IPCA Laboratories schedules Q2 FY27 earnings call for November 5, 2026

Board & Shareholder Meetings View source PDF Explain this filing

IPCALAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.9%Reaction day

₹1983.00

prior close

₹1943.20

announcement price

In-mkt

timing

Nifty Midcap 150marketpendingvs market: pending

Pharmaceuticals peers, median of 170sector+0.6%-3.5% vs sector

On the reaction day the stock moved 3.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.4

10m

-0.5

15m

-0.4

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.9pendingpending+0.6-3.5

Next day

—————

15d

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

IPCA Laboratories will discuss its Q2 FY27 earnings and business update on November 5, 2026, from 4:00 pm to 5:00 pm IST, after announcing the quarter's unaudited results. Managing Director A K Jain and Harish Kamath will represent management. The investor call is hosted by Dam Capital Advisors.

Likely market impact

The call may help investors assess quarterly performance and the business outlook, but no financial figures are provided.